Original language | English |
---|---|
Pages (from-to) | 2558-2560 |
Number of pages | 3 |
Journal | Addiction |
Volume | 117 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sept 2022 |
Keywords
- Assessment
- cannabis
- dose
- measurement
- standardization
- toolkit
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Addiction, Vol. 117, No. 9, 09.2022, p. 2558-2560.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The iCannTookit
T2 - a consensus-based, flexible framework for measuring contemporary cannabis use
AU - Lorenzetti, Valentina
AU - Hindocha, Chandni
AU - Petrilli, Kat
AU - Griffiths, Paul
AU - Brown, Jamie
AU - Castillo-Carniglia, Álvaro
AU - Caulkins, Jonathan P.
AU - Englund, Amir
AU - El Sohly, Mahmoud A.
AU - Gage, Suzanne H.
AU - Groshkova, Teodora
AU - Gual, Antoni
AU - Hammond, David
AU - Lawn, Will
AU - López-Pelayo, Hugo
AU - Manthey, Jakob
AU - Mokrysz, Claire
AU - Liccardo Pacula, Rosalie
AU - van Laar, Margriet
AU - Vandrey, Ryan
AU - Wadsworth, Elle
AU - Winstock, Adam
AU - Hall, Wayne
AU - Curran, H. Valerie
AU - Freeman, Tom P.
N1 - Funding Information: This study was funded by the Society for the Study of Addiction, European Monitoring Centre for Drugs and Drug Addiction. H.L.P. works under the CERCA Programme/Generalitat de Catalunya and receives funding from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III through a ‘Juan Rodes’ contract (JR19/00025). Funding Information: A.G. received funding from Novartis for work outside this area (a Phase III cocaine trial). A.E. has received a speaker honorarium from GW Pharmaceuticals. A.W. is the founder of the Global Drug Survey. C.H. became a full‐time employee of GW Pharmaceuticals after the consensus meeting. D.H. has served as a paid expert witness on behalf of public health authorities in Canada in response to legal challenges from the cannabis industry. H.L. has received honoraria and travel grants from Janssen and Lundbeck. J.B. has received unrestricted research funding to study smoking cessation from companies who manufacture smoking cessation medications (Pfizer and J&J). R.V. receives consulting fees for Canopy Health Innovations and Syqe Medical Ltd, and is on the Scientific Advisory Board for MyMD Pharmaceuticals and Artiam Bio Inc. V.C. has consulted for Janssen. V.L., W.H., T.P.F., E.W., T.G., W.L., A.C.C., J.P.C., R.L.P., M.v.L., K.P., P.G., M.A.E., S.H.G., J.M. and C.M. have no competing interests to declare.
PY - 2022/9
Y1 - 2022/9
KW - Assessment
KW - cannabis
KW - dose
KW - measurement
KW - standardization
KW - toolkit
UR - http://www.scopus.com/inward/record.url?scp=85131349890&partnerID=8YFLogxK
U2 - 10.1111/add.15956
DO - 10.1111/add.15956
M3 - Letter
AN - SCOPUS:85131349890
SN - 0965-2140
VL - 117
SP - 2558
EP - 2560
JO - Addiction
JF - Addiction
IS - 9
ER -